Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | ATM S83L |
| Therapy | Olaparib |
| Indication/Tumor Type | Advanced Solid Tumor |
| Response Type | sensitive |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| ATM S83L | Advanced Solid Tumor | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with Lynparza (olaparib) inhibited survival and proliferation of cells expressing ATM S83L in a high-throughput cell culture assay (PMID: 40580951). | 40580951 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (40580951) | Functional assessment of all ATM SNVs using prime editing and deep learning. | Full reference... |